Siegfried(SFZN)
Switzerland - ZofingenCDMO (Contract Manufacturing)
Focus: Siegfried is a Swiss-headquartered CDMO (Contract Development and Manufacturing Organization) operating at mid-market scale with 1,001–5,000 employees. The company provides outsourced manufacturing and development services to pharmaceutical clients globally.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
75+22 this month
Hot — 84 jobs added in 30d
Net +22 (84 new, 62 removed). Aggressive expansion phase.
Should You Work at Siegfried?
AI assessmentSiegfried offers stable, public-company infrastructure and active hiring in operations-focused roles, but lack of financial transparency and CDMO sector cyclicality warrant caution before committing to long-term career moves.
Why Work Here
- Established public company (ticker SFZN) with stable footing in the high-demand CDMO sector, reducing startup/bankruptcy risk.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Favipiravir
Covid19Open Jobs (75)
Help build intelligence for Siegfried
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.